Global Immunoadsorption Columns Market Growth (Status and Outlook) 2026-2032
The global Immunoadsorption Columns market size is predicted to grow from US$ 33.85 million in 2025 to US$ 57.01 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.
Immunoadsorption columns are extracorporeal, single use or regenerable disposable devices used in therapeutic apheresis or plasma purification. After plasma separation, the patient?s plasma is passed through an adsorption bed containing specific or semi specific ligands that selectively bind and remove pathogenic antibodies, immunoglobulins, immune complexes, or defined alloantibodies. This enables rapid reduction of antibody burden in relevant clinical settings and, compared with therapeutic plasma exchange (TPE), typically provides greater target selectivity while reducing reliance on replacement fluids. The core technology paradigm centers on ligand immobilization and hemocompatibility engineering. Common ligands include Protein A affinity ligands, synthetic amino acid or peptide ligands, and glycan structures associated with blood group antigens. The adsorbent matrix is usually a high surface area porous substrate, engineered to balance pressure drop and binding capacity, while controlling leachables and ensuring consistent sterilization and lot to lot performance. Products are commonly delivered as a single use single column or a regenerable dual column system, and are used together with plasma separators, tubing sets, and monitoring equipment as an integrated therapy setup, with commercial charging typically on a per treatment or per course basis. Typical applications span autoimmune and connective tissue diseases, neuroimmunological disorders, and transplant desensitization and antibody mediated rejection (AMR) management. Representative examples include IMMUSORBA PH for autoimmune diseases, IMMUSORBA TR for neurological indications, GLOBAFFIN and TheraSorb Ig omni for broad immunoglobulin removal, and Glycosorb ABO for lowering anti A and anti B antibody titers in ABO incompatible transplantation. Primary customers and users are apheresis teams in tertiary hospitals, particularly in nephrology, rheumatology, neurology, intensive care, and transplant centers. Procedures are most often performed via a plasma pathway with anticoagulation and pressure monitoring. Some products emphasize no need for plasma replacement to reduce infection and allergy related risks, while differentiation across manufacturers is mainly reflected in ligand target spectrum and indication positioning, such as the ImmunoCore and DNA230 product lines.
Immunoadsorption columns are a core consumable in therapeutic apheresis and plasma purification. Their value lies in selectively removing pathogenic factors from separated plasma via immobilized ligands, enabling rapid antibody-burden reduction in autoimmune and neuroimmunological diseases, transplant desensitization, and antibody-mediated rejection scenarios, while in many pathways reducing or avoiding the need for replacement fluids used in therapeutic plasma exchange (TPE). Product differentiation is primarily driven by ligand target spectrum and engineering choices. One route, represented by Protein A?based affinity ligands, emphasizes high-affinity capture of IgG and related antibodies. Another route uses synthetic amino-acid or peptide ligands, highlighting broad immunoglobulin and immune-complex removal while avoiding animal-derived components. A third route applies antigen- or glycan-structure?driven specific adsorption, targeting defined alloantibodies such as anti-A and anti-B. Commercially, suppliers typically deliver either single-use columns or regenerable dual-column systems, and build quality systems around balancing pressure drop and binding capacity, controlling leachables, ensuring sterilization consistency, and maintaining hemocompatibility. In practice, columns are deployed with plasma separators, tubing sets, and monitoring systems as a reproducible therapy setup, and are commonly charged on a per-treatment or per-course basis. Operational focus for clinical teams centers on anticoagulation strategy, pressure monitoring, regeneration workflow, and adverse-event management.
From the supply side, immunoadsorption column R&D and manufacturing capabilities show clear regional concentration. Core production and technical accumulation are anchored in medical-device strongholds such as Germany and Japan, with representative suppliers also emerging in Northern Europe and China. This reflects a high bar that extends beyond mechanical fabrication to encompass materials chemistry, immobilization processes, and regulatory readiness, together with long-cycle clinical evidence building. At the company level, some global device groups extend established therapeutic apheresis platforms into broader product portfolios; some specialists differentiate around a single, well-defined clinical niche via specific antibody removal; and some China-based manufacturers scale product lines rapidly under the pull of domestic registration and hospital demand. The supply structure also highlights parallel technology tracks: broad immunoglobulin removal coexists with highly specific antibody removal, and single-use offerings coexist with regenerable reuse models. These choices materially affect hospital workflow, reprocessing compliance, and cost accounting, and ultimately translate into market differences in indication focus, operational complexity, course organization, and total cost of ownership.
On the commercialization side, regulation and clinical pathways impose strong constraints. Immunoadsorption columns are rarely ?globally interchangeable?; instead, markets are segmented by country- or region-specific registrations and labeling, making CE-marked compliance a key enabler for European availability while manufacturers often explicitly note variations in availability by national site. This implies that the same product may correspond to different legal-manufacturer information, instructions for use, and indication statements across markets. Clinical adoption also displays pronounced regional characteristics. For example, Japan has higher utilization density and more established pathways for certain immunoadsorption products, whereas antibody-specific adsorption for transplant desensitization, supported by clear clinical needs and standardized workflows, can more readily expand across multiple countries and centers. In China, market formation is more strongly driven by local registration and hospital blood-purification systems, with domestic brands entering application loops through registration and hospital access and coexisting alongside imported offerings. Overall, market expansion tends to be an iterative, compliance- and evidence-led process: manufacturers must simultaneously address manufacturing consistency and clinical evidence, regional registrations and channel coverage, and system-level integration with equipment and consumable kits to achieve sustainable scale across varying reimbursement environments and departmental structures.
LPI (LP Information)' newest research report, the ?Immunoadsorption Columns Industry Forecast? looks at past sales and reviews total world Immunoadsorption Columns sales in 2025, providing a comprehensive analysis by region and market sector of projected Immunoadsorption Columns sales for 2026 through 2032. With Immunoadsorption Columns sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoadsorption Columns industry.
This Insight Report provides a comprehensive analysis of the global Immunoadsorption Columns landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunoadsorption Columns portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immunoadsorption Columns market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoadsorption Columns and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoadsorption Columns.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunoadsorption Columns market by product type, application, key players and key regions and countries.
Segmentation by Type:
Immunoadsorption columns are extracorporeal, single use or regenerable disposable devices used in therapeutic apheresis or plasma purification. After plasma separation, the patient?s plasma is passed through an adsorption bed containing specific or semi specific ligands that selectively bind and remove pathogenic antibodies, immunoglobulins, immune complexes, or defined alloantibodies. This enables rapid reduction of antibody burden in relevant clinical settings and, compared with therapeutic plasma exchange (TPE), typically provides greater target selectivity while reducing reliance on replacement fluids. The core technology paradigm centers on ligand immobilization and hemocompatibility engineering. Common ligands include Protein A affinity ligands, synthetic amino acid or peptide ligands, and glycan structures associated with blood group antigens. The adsorbent matrix is usually a high surface area porous substrate, engineered to balance pressure drop and binding capacity, while controlling leachables and ensuring consistent sterilization and lot to lot performance. Products are commonly delivered as a single use single column or a regenerable dual column system, and are used together with plasma separators, tubing sets, and monitoring equipment as an integrated therapy setup, with commercial charging typically on a per treatment or per course basis. Typical applications span autoimmune and connective tissue diseases, neuroimmunological disorders, and transplant desensitization and antibody mediated rejection (AMR) management. Representative examples include IMMUSORBA PH for autoimmune diseases, IMMUSORBA TR for neurological indications, GLOBAFFIN and TheraSorb Ig omni for broad immunoglobulin removal, and Glycosorb ABO for lowering anti A and anti B antibody titers in ABO incompatible transplantation. Primary customers and users are apheresis teams in tertiary hospitals, particularly in nephrology, rheumatology, neurology, intensive care, and transplant centers. Procedures are most often performed via a plasma pathway with anticoagulation and pressure monitoring. Some products emphasize no need for plasma replacement to reduce infection and allergy related risks, while differentiation across manufacturers is mainly reflected in ligand target spectrum and indication positioning, such as the ImmunoCore and DNA230 product lines.
Immunoadsorption columns are a core consumable in therapeutic apheresis and plasma purification. Their value lies in selectively removing pathogenic factors from separated plasma via immobilized ligands, enabling rapid antibody-burden reduction in autoimmune and neuroimmunological diseases, transplant desensitization, and antibody-mediated rejection scenarios, while in many pathways reducing or avoiding the need for replacement fluids used in therapeutic plasma exchange (TPE). Product differentiation is primarily driven by ligand target spectrum and engineering choices. One route, represented by Protein A?based affinity ligands, emphasizes high-affinity capture of IgG and related antibodies. Another route uses synthetic amino-acid or peptide ligands, highlighting broad immunoglobulin and immune-complex removal while avoiding animal-derived components. A third route applies antigen- or glycan-structure?driven specific adsorption, targeting defined alloantibodies such as anti-A and anti-B. Commercially, suppliers typically deliver either single-use columns or regenerable dual-column systems, and build quality systems around balancing pressure drop and binding capacity, controlling leachables, ensuring sterilization consistency, and maintaining hemocompatibility. In practice, columns are deployed with plasma separators, tubing sets, and monitoring systems as a reproducible therapy setup, and are commonly charged on a per-treatment or per-course basis. Operational focus for clinical teams centers on anticoagulation strategy, pressure monitoring, regeneration workflow, and adverse-event management.
From the supply side, immunoadsorption column R&D and manufacturing capabilities show clear regional concentration. Core production and technical accumulation are anchored in medical-device strongholds such as Germany and Japan, with representative suppliers also emerging in Northern Europe and China. This reflects a high bar that extends beyond mechanical fabrication to encompass materials chemistry, immobilization processes, and regulatory readiness, together with long-cycle clinical evidence building. At the company level, some global device groups extend established therapeutic apheresis platforms into broader product portfolios; some specialists differentiate around a single, well-defined clinical niche via specific antibody removal; and some China-based manufacturers scale product lines rapidly under the pull of domestic registration and hospital demand. The supply structure also highlights parallel technology tracks: broad immunoglobulin removal coexists with highly specific antibody removal, and single-use offerings coexist with regenerable reuse models. These choices materially affect hospital workflow, reprocessing compliance, and cost accounting, and ultimately translate into market differences in indication focus, operational complexity, course organization, and total cost of ownership.
On the commercialization side, regulation and clinical pathways impose strong constraints. Immunoadsorption columns are rarely ?globally interchangeable?; instead, markets are segmented by country- or region-specific registrations and labeling, making CE-marked compliance a key enabler for European availability while manufacturers often explicitly note variations in availability by national site. This implies that the same product may correspond to different legal-manufacturer information, instructions for use, and indication statements across markets. Clinical adoption also displays pronounced regional characteristics. For example, Japan has higher utilization density and more established pathways for certain immunoadsorption products, whereas antibody-specific adsorption for transplant desensitization, supported by clear clinical needs and standardized workflows, can more readily expand across multiple countries and centers. In China, market formation is more strongly driven by local registration and hospital blood-purification systems, with domestic brands entering application loops through registration and hospital access and coexisting alongside imported offerings. Overall, market expansion tends to be an iterative, compliance- and evidence-led process: manufacturers must simultaneously address manufacturing consistency and clinical evidence, regional registrations and channel coverage, and system-level integration with equipment and consumable kits to achieve sustainable scale across varying reimbursement environments and departmental structures.
LPI (LP Information)' newest research report, the ?Immunoadsorption Columns Industry Forecast? looks at past sales and reviews total world Immunoadsorption Columns sales in 2025, providing a comprehensive analysis by region and market sector of projected Immunoadsorption Columns sales for 2026 through 2032. With Immunoadsorption Columns sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoadsorption Columns industry.
This Insight Report provides a comprehensive analysis of the global Immunoadsorption Columns landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunoadsorption Columns portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immunoadsorption Columns market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoadsorption Columns and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoadsorption Columns.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunoadsorption Columns market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Single Use Immunoadsorption Columns
- Reuse Immunoadsorption Columns
- Single-ligand
- Composite / Multi-ligand
- Sepharose Carrier Matrix
- Other Inert Polysaccharide Matrix
- Hospitals
- Specialty Clinics
- Academic & Research Centres
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Asahi Kasei Medical Co., Ltd.
- Fresenius Medical Care
- Glycorex Transplantation AB
- Guangzhou Koncen BioScience Co., Ltd.
- Jafron Biomedical Co., Ltd.
- Miltenyi Biotec
- POCARD Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunoadsorption Columns Market Size (2021-2032)
2.1.2 Immunoadsorption Columns Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Immunoadsorption Columns by Country/Region (2021, 2025 & 2032)
2.2 Immunoadsorption Columns Segment by Type
2.2.1 Single Use Immunoadsorption Columns
2.2.2 Reuse Immunoadsorption Columns
2.2.3 Immunoadsorption Columns Market Size by Type
2.2.3.1 Immunoadsorption Columns Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
2.3 Immunoadsorption Columns Segment by Ligand Composition
2.3.1 Single-ligand
2.3.2 Composite / Multi-ligand
2.3.3 Immunoadsorption Columns Market Size by Ligand Composition
2.3.3.1 Immunoadsorption Columns Market Size CAGR by Ligand Composition (2021 VS 2025 VS 2032)
2.3.3.2 Global Immunoadsorption Columns Market Size Market Share by Ligand Composition (2021-2026)
2.4 Immunoadsorption Columns Segment by Carrier Matrix
2.4.1 Sepharose Carrier Matrix
2.4.2 Other Inert Polysaccharide Matrix
2.4.3 Immunoadsorption Columns Market Size by Carrier Matrix
2.4.3.1 Immunoadsorption Columns Market Size CAGR by Carrier Matrix (2021 VS 2025 VS 2032)
2.4.3.2 Global Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2021-2026)
2.5 Immunoadsorption Columns Segment by Application
2.5.1 Hospitals
2.5.2 Specialty Clinics
2.5.3 Academic & Research Centres
2.5.4 Others
2.5.5 Immunoadsorption Columns Market Size by Application
2.5.5.1 Immunoadsorption Columns Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
3 IMMUNOADSORPTION COLUMNS MARKET SIZE BY PLAYER
3.1 Immunoadsorption Columns Market Size Market Share by Player
3.1.1 Global Immunoadsorption Columns Revenue by Player (2021-2026)
3.1.2 Global Immunoadsorption Columns Revenue Market Share by Player (2021-2026)
3.2 Global Immunoadsorption Columns Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNOADSORPTION COLUMNS BY REGION
4.1 Immunoadsorption Columns Market Size by Region (2021-2026)
4.2 Global Immunoadsorption Columns Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immunoadsorption Columns Market Size Growth (2021-2026)
4.4 APAC Immunoadsorption Columns Market Size Growth (2021-2026)
4.5 Europe Immunoadsorption Columns Market Size Growth (2021-2026)
4.6 Middle East & Africa Immunoadsorption Columns Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Immunoadsorption Columns Market Size by Country (2021-2026)
5.2 Americas Immunoadsorption Columns Market Size by Type (2021-2026)
5.3 Americas Immunoadsorption Columns Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunoadsorption Columns Market Size by Region (2021-2026)
6.2 APAC Immunoadsorption Columns Market Size by Type (2021-2026)
6.3 APAC Immunoadsorption Columns Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immunoadsorption Columns Market Size by Country (2021-2026)
7.2 Europe Immunoadsorption Columns Market Size by Type (2021-2026)
7.3 Europe Immunoadsorption Columns Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunoadsorption Columns by Region (2021-2026)
8.2 Middle East & Africa Immunoadsorption Columns Market Size by Type (2021-2026)
8.3 Middle East & Africa Immunoadsorption Columns Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNOADSORPTION COLUMNS MARKET FORECAST
10.1 Global Immunoadsorption Columns Forecast by Region (2027-2032)
10.1.1 Global Immunoadsorption Columns Forecast by Region (2027-2032)
10.1.2 Americas Immunoadsorption Columns Forecast
10.1.3 APAC Immunoadsorption Columns Forecast
10.1.4 Europe Immunoadsorption Columns Forecast
10.1.5 Middle East & Africa Immunoadsorption Columns Forecast
10.2 Americas Immunoadsorption Columns Forecast by Country (2027-2032)
10.2.1 United States Market Immunoadsorption Columns Forecast
10.2.2 Canada Market Immunoadsorption Columns Forecast
10.2.3 Mexico Market Immunoadsorption Columns Forecast
10.2.4 Brazil Market Immunoadsorption Columns Forecast
10.3 APAC Immunoadsorption Columns Forecast by Region (2027-2032)
10.3.1 China Immunoadsorption Columns Market Forecast
10.3.2 Japan Market Immunoadsorption Columns Forecast
10.3.3 Korea Market Immunoadsorption Columns Forecast
10.3.4 Southeast Asia Market Immunoadsorption Columns Forecast
10.3.5 India Market Immunoadsorption Columns Forecast
10.3.6 Australia Market Immunoadsorption Columns Forecast
10.4 Europe Immunoadsorption Columns Forecast by Country (2027-2032)
10.4.1 Germany Market Immunoadsorption Columns Forecast
10.4.2 France Market Immunoadsorption Columns Forecast
10.4.3 UK Market Immunoadsorption Columns Forecast
10.4.4 Italy Market Immunoadsorption Columns Forecast
10.4.5 Russia Market Immunoadsorption Columns Forecast
10.5 Middle East & Africa Immunoadsorption Columns Forecast by Region (2027-2032)
10.5.1 Egypt Market Immunoadsorption Columns Forecast
10.5.2 South Africa Market Immunoadsorption Columns Forecast
10.5.3 Israel Market Immunoadsorption Columns Forecast
10.5.4 Turkey Market Immunoadsorption Columns Forecast
10.6 Global Immunoadsorption Columns Forecast by Type (2027-2032)
10.7 Global Immunoadsorption Columns Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Immunoadsorption Columns Forecast
11 KEY PLAYERS ANALYSIS
11.1 Asahi Kasei Medical Co., Ltd.
11.1.1 Asahi Kasei Medical Co., Ltd. Company Information
11.1.2 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product Offered
11.1.3 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Asahi Kasei Medical Co., Ltd. Main Business Overview
11.1.5 Asahi Kasei Medical Co., Ltd. Latest Developments
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Information
11.2.2 Fresenius Medical Care Immunoadsorption Columns Product Offered
11.2.3 Fresenius Medical Care Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fresenius Medical Care Main Business Overview
11.2.5 Fresenius Medical Care Latest Developments
11.3 Glycorex Transplantation AB
11.3.1 Glycorex Transplantation AB Company Information
11.3.2 Glycorex Transplantation AB Immunoadsorption Columns Product Offered
11.3.3 Glycorex Transplantation AB Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Glycorex Transplantation AB Main Business Overview
11.3.5 Glycorex Transplantation AB Latest Developments
11.4 Guangzhou Koncen BioScience Co., Ltd.
11.4.1 Guangzhou Koncen BioScience Co., Ltd. Company Information
11.4.2 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product Offered
11.4.3 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Guangzhou Koncen BioScience Co., Ltd. Main Business Overview
11.4.5 Guangzhou Koncen BioScience Co., Ltd. Latest Developments
11.5 Jafron Biomedical Co., Ltd.
11.5.1 Jafron Biomedical Co., Ltd. Company Information
11.5.2 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product Offered
11.5.3 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Jafron Biomedical Co., Ltd. Main Business Overview
11.5.5 Jafron Biomedical Co., Ltd. Latest Developments
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Information
11.6.2 Miltenyi Biotec Immunoadsorption Columns Product Offered
11.6.3 Miltenyi Biotec Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Miltenyi Biotec Main Business Overview
11.6.5 Miltenyi Biotec Latest Developments
11.7 POCARD Ltd.
11.7.1 POCARD Ltd. Company Information
11.7.2 POCARD Ltd. Immunoadsorption Columns Product Offered
11.7.3 POCARD Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 POCARD Ltd. Main Business Overview
11.7.5 POCARD Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunoadsorption Columns Market Size (2021-2032)
2.1.2 Immunoadsorption Columns Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Immunoadsorption Columns by Country/Region (2021, 2025 & 2032)
2.2 Immunoadsorption Columns Segment by Type
2.2.1 Single Use Immunoadsorption Columns
2.2.2 Reuse Immunoadsorption Columns
2.2.3 Immunoadsorption Columns Market Size by Type
2.2.3.1 Immunoadsorption Columns Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
2.3 Immunoadsorption Columns Segment by Ligand Composition
2.3.1 Single-ligand
2.3.2 Composite / Multi-ligand
2.3.3 Immunoadsorption Columns Market Size by Ligand Composition
2.3.3.1 Immunoadsorption Columns Market Size CAGR by Ligand Composition (2021 VS 2025 VS 2032)
2.3.3.2 Global Immunoadsorption Columns Market Size Market Share by Ligand Composition (2021-2026)
2.4 Immunoadsorption Columns Segment by Carrier Matrix
2.4.1 Sepharose Carrier Matrix
2.4.2 Other Inert Polysaccharide Matrix
2.4.3 Immunoadsorption Columns Market Size by Carrier Matrix
2.4.3.1 Immunoadsorption Columns Market Size CAGR by Carrier Matrix (2021 VS 2025 VS 2032)
2.4.3.2 Global Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2021-2026)
2.5 Immunoadsorption Columns Segment by Application
2.5.1 Hospitals
2.5.2 Specialty Clinics
2.5.3 Academic & Research Centres
2.5.4 Others
2.5.5 Immunoadsorption Columns Market Size by Application
2.5.5.1 Immunoadsorption Columns Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
3 IMMUNOADSORPTION COLUMNS MARKET SIZE BY PLAYER
3.1 Immunoadsorption Columns Market Size Market Share by Player
3.1.1 Global Immunoadsorption Columns Revenue by Player (2021-2026)
3.1.2 Global Immunoadsorption Columns Revenue Market Share by Player (2021-2026)
3.2 Global Immunoadsorption Columns Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNOADSORPTION COLUMNS BY REGION
4.1 Immunoadsorption Columns Market Size by Region (2021-2026)
4.2 Global Immunoadsorption Columns Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immunoadsorption Columns Market Size Growth (2021-2026)
4.4 APAC Immunoadsorption Columns Market Size Growth (2021-2026)
4.5 Europe Immunoadsorption Columns Market Size Growth (2021-2026)
4.6 Middle East & Africa Immunoadsorption Columns Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Immunoadsorption Columns Market Size by Country (2021-2026)
5.2 Americas Immunoadsorption Columns Market Size by Type (2021-2026)
5.3 Americas Immunoadsorption Columns Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunoadsorption Columns Market Size by Region (2021-2026)
6.2 APAC Immunoadsorption Columns Market Size by Type (2021-2026)
6.3 APAC Immunoadsorption Columns Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immunoadsorption Columns Market Size by Country (2021-2026)
7.2 Europe Immunoadsorption Columns Market Size by Type (2021-2026)
7.3 Europe Immunoadsorption Columns Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunoadsorption Columns by Region (2021-2026)
8.2 Middle East & Africa Immunoadsorption Columns Market Size by Type (2021-2026)
8.3 Middle East & Africa Immunoadsorption Columns Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNOADSORPTION COLUMNS MARKET FORECAST
10.1 Global Immunoadsorption Columns Forecast by Region (2027-2032)
10.1.1 Global Immunoadsorption Columns Forecast by Region (2027-2032)
10.1.2 Americas Immunoadsorption Columns Forecast
10.1.3 APAC Immunoadsorption Columns Forecast
10.1.4 Europe Immunoadsorption Columns Forecast
10.1.5 Middle East & Africa Immunoadsorption Columns Forecast
10.2 Americas Immunoadsorption Columns Forecast by Country (2027-2032)
10.2.1 United States Market Immunoadsorption Columns Forecast
10.2.2 Canada Market Immunoadsorption Columns Forecast
10.2.3 Mexico Market Immunoadsorption Columns Forecast
10.2.4 Brazil Market Immunoadsorption Columns Forecast
10.3 APAC Immunoadsorption Columns Forecast by Region (2027-2032)
10.3.1 China Immunoadsorption Columns Market Forecast
10.3.2 Japan Market Immunoadsorption Columns Forecast
10.3.3 Korea Market Immunoadsorption Columns Forecast
10.3.4 Southeast Asia Market Immunoadsorption Columns Forecast
10.3.5 India Market Immunoadsorption Columns Forecast
10.3.6 Australia Market Immunoadsorption Columns Forecast
10.4 Europe Immunoadsorption Columns Forecast by Country (2027-2032)
10.4.1 Germany Market Immunoadsorption Columns Forecast
10.4.2 France Market Immunoadsorption Columns Forecast
10.4.3 UK Market Immunoadsorption Columns Forecast
10.4.4 Italy Market Immunoadsorption Columns Forecast
10.4.5 Russia Market Immunoadsorption Columns Forecast
10.5 Middle East & Africa Immunoadsorption Columns Forecast by Region (2027-2032)
10.5.1 Egypt Market Immunoadsorption Columns Forecast
10.5.2 South Africa Market Immunoadsorption Columns Forecast
10.5.3 Israel Market Immunoadsorption Columns Forecast
10.5.4 Turkey Market Immunoadsorption Columns Forecast
10.6 Global Immunoadsorption Columns Forecast by Type (2027-2032)
10.7 Global Immunoadsorption Columns Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Immunoadsorption Columns Forecast
11 KEY PLAYERS ANALYSIS
11.1 Asahi Kasei Medical Co., Ltd.
11.1.1 Asahi Kasei Medical Co., Ltd. Company Information
11.1.2 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product Offered
11.1.3 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Asahi Kasei Medical Co., Ltd. Main Business Overview
11.1.5 Asahi Kasei Medical Co., Ltd. Latest Developments
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Information
11.2.2 Fresenius Medical Care Immunoadsorption Columns Product Offered
11.2.3 Fresenius Medical Care Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fresenius Medical Care Main Business Overview
11.2.5 Fresenius Medical Care Latest Developments
11.3 Glycorex Transplantation AB
11.3.1 Glycorex Transplantation AB Company Information
11.3.2 Glycorex Transplantation AB Immunoadsorption Columns Product Offered
11.3.3 Glycorex Transplantation AB Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Glycorex Transplantation AB Main Business Overview
11.3.5 Glycorex Transplantation AB Latest Developments
11.4 Guangzhou Koncen BioScience Co., Ltd.
11.4.1 Guangzhou Koncen BioScience Co., Ltd. Company Information
11.4.2 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product Offered
11.4.3 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Guangzhou Koncen BioScience Co., Ltd. Main Business Overview
11.4.5 Guangzhou Koncen BioScience Co., Ltd. Latest Developments
11.5 Jafron Biomedical Co., Ltd.
11.5.1 Jafron Biomedical Co., Ltd. Company Information
11.5.2 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product Offered
11.5.3 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Jafron Biomedical Co., Ltd. Main Business Overview
11.5.5 Jafron Biomedical Co., Ltd. Latest Developments
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Information
11.6.2 Miltenyi Biotec Immunoadsorption Columns Product Offered
11.6.3 Miltenyi Biotec Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Miltenyi Biotec Main Business Overview
11.6.5 Miltenyi Biotec Latest Developments
11.7 POCARD Ltd.
11.7.1 POCARD Ltd. Company Information
11.7.2 POCARD Ltd. Immunoadsorption Columns Product Offered
11.7.3 POCARD Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 POCARD Ltd. Main Business Overview
11.7.5 POCARD Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immunoadsorption Columns Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Immunoadsorption Columns Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Use Immunoadsorption Columns
Table 4. Major Players of Reuse Immunoadsorption Columns
Table 5. Immunoadsorption Columns Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Single-ligand
Table 9. Major Players of Composite / Multi-ligand
Table 10. Immunoadsorption Columns Market Size CAGR by Ligand Composition (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Immunoadsorption Columns Market Size by Ligand Composition (2021-2026) & ($ millions)
Table 12. Global Immunoadsorption Columns Market Size Market Share by Ligand Composition (2021-2026)
Table 13. Major Players of Sepharose Carrier Matrix
Table 14. Major Players of Other Inert Polysaccharide Matrix
Table 15. Immunoadsorption Columns Market Size CAGR by Carrier Matrix (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Immunoadsorption Columns Market Size by Carrier Matrix (2021-2026) & ($ millions)
Table 17. Global Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2021-2026)
Table 18. Immunoadsorption Columns Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Table 21. Global Immunoadsorption Columns Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Immunoadsorption Columns Revenue Market Share by Player (2021-2026)
Table 23. Immunoadsorption Columns Key Players Head office and Products Offered
Table 24. Immunoadsorption Columns Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Immunoadsorption Columns Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Table 29. Global Immunoadsorption Columns Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Immunoadsorption Columns Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Immunoadsorption Columns Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Immunoadsorption Columns Market Size Market Share by Country (2021-2026)
Table 33. Americas Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Table 35. Americas Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Table 37. APAC Immunoadsorption Columns Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Table 39. APAC Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Immunoadsorption Columns Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Immunoadsorption Columns Market Size Market Share by Country (2021-2026)
Table 43. Europe Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Immunoadsorption Columns Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Immunoadsorption Columns
Table 49. Key Market Challenges & Risks of Immunoadsorption Columns
Table 50. Key Industry Trends of Immunoadsorption Columns
Table 51. Global Immunoadsorption Columns Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Immunoadsorption Columns Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Immunoadsorption Columns Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Immunoadsorption Columns Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Asahi Kasei Medical Co., Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 56. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product Offered
Table 57. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Asahi Kasei Medical Co., Ltd. Main Business
Table 59. Asahi Kasei Medical Co., Ltd. Latest Developments
Table 60. Fresenius Medical Care Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 61. Fresenius Medical Care Immunoadsorption Columns Product Offered
Table 62. Fresenius Medical Care Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Fresenius Medical Care Main Business
Table 64. Fresenius Medical Care Latest Developments
Table 65. Glycorex Transplantation AB Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 66. Glycorex Transplantation AB Immunoadsorption Columns Product Offered
Table 67. Glycorex Transplantation AB Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Glycorex Transplantation AB Main Business
Table 69. Glycorex Transplantation AB Latest Developments
Table 70. Guangzhou Koncen BioScience Co., Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 71. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product Offered
Table 72. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Guangzhou Koncen BioScience Co., Ltd. Main Business
Table 74. Guangzhou Koncen BioScience Co., Ltd. Latest Developments
Table 75. Jafron Biomedical Co., Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 76. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product Offered
Table 77. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Jafron Biomedical Co., Ltd. Main Business
Table 79. Jafron Biomedical Co., Ltd. Latest Developments
Table 80. Miltenyi Biotec Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 81. Miltenyi Biotec Immunoadsorption Columns Product Offered
Table 82. Miltenyi Biotec Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Miltenyi Biotec Main Business
Table 84. Miltenyi Biotec Latest Developments
Table 85. POCARD Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 86. POCARD Ltd. Immunoadsorption Columns Product Offered
Table 87. POCARD Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. POCARD Ltd. Main Business
Table 89. POCARD Ltd. Latest Developments
Table 1. Immunoadsorption Columns Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Immunoadsorption Columns Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Use Immunoadsorption Columns
Table 4. Major Players of Reuse Immunoadsorption Columns
Table 5. Immunoadsorption Columns Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Single-ligand
Table 9. Major Players of Composite / Multi-ligand
Table 10. Immunoadsorption Columns Market Size CAGR by Ligand Composition (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Immunoadsorption Columns Market Size by Ligand Composition (2021-2026) & ($ millions)
Table 12. Global Immunoadsorption Columns Market Size Market Share by Ligand Composition (2021-2026)
Table 13. Major Players of Sepharose Carrier Matrix
Table 14. Major Players of Other Inert Polysaccharide Matrix
Table 15. Immunoadsorption Columns Market Size CAGR by Carrier Matrix (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Immunoadsorption Columns Market Size by Carrier Matrix (2021-2026) & ($ millions)
Table 17. Global Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2021-2026)
Table 18. Immunoadsorption Columns Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Table 21. Global Immunoadsorption Columns Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Immunoadsorption Columns Revenue Market Share by Player (2021-2026)
Table 23. Immunoadsorption Columns Key Players Head office and Products Offered
Table 24. Immunoadsorption Columns Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Immunoadsorption Columns Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Table 29. Global Immunoadsorption Columns Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Immunoadsorption Columns Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Immunoadsorption Columns Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Immunoadsorption Columns Market Size Market Share by Country (2021-2026)
Table 33. Americas Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Table 35. Americas Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Table 37. APAC Immunoadsorption Columns Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Table 39. APAC Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Immunoadsorption Columns Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Immunoadsorption Columns Market Size Market Share by Country (2021-2026)
Table 43. Europe Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Immunoadsorption Columns Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Immunoadsorption Columns Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Immunoadsorption Columns Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Immunoadsorption Columns
Table 49. Key Market Challenges & Risks of Immunoadsorption Columns
Table 50. Key Industry Trends of Immunoadsorption Columns
Table 51. Global Immunoadsorption Columns Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Immunoadsorption Columns Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Immunoadsorption Columns Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Immunoadsorption Columns Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Asahi Kasei Medical Co., Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 56. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product Offered
Table 57. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Asahi Kasei Medical Co., Ltd. Main Business
Table 59. Asahi Kasei Medical Co., Ltd. Latest Developments
Table 60. Fresenius Medical Care Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 61. Fresenius Medical Care Immunoadsorption Columns Product Offered
Table 62. Fresenius Medical Care Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Fresenius Medical Care Main Business
Table 64. Fresenius Medical Care Latest Developments
Table 65. Glycorex Transplantation AB Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 66. Glycorex Transplantation AB Immunoadsorption Columns Product Offered
Table 67. Glycorex Transplantation AB Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Glycorex Transplantation AB Main Business
Table 69. Glycorex Transplantation AB Latest Developments
Table 70. Guangzhou Koncen BioScience Co., Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 71. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product Offered
Table 72. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Guangzhou Koncen BioScience Co., Ltd. Main Business
Table 74. Guangzhou Koncen BioScience Co., Ltd. Latest Developments
Table 75. Jafron Biomedical Co., Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 76. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product Offered
Table 77. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Jafron Biomedical Co., Ltd. Main Business
Table 79. Jafron Biomedical Co., Ltd. Latest Developments
Table 80. Miltenyi Biotec Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 81. Miltenyi Biotec Immunoadsorption Columns Product Offered
Table 82. Miltenyi Biotec Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Miltenyi Biotec Main Business
Table 84. Miltenyi Biotec Latest Developments
Table 85. POCARD Ltd. Details, Company Type, Immunoadsorption Columns Area Served and Its Competitors
Table 86. POCARD Ltd. Immunoadsorption Columns Product Offered
Table 87. POCARD Ltd. Immunoadsorption Columns Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. POCARD Ltd. Main Business
Table 89. POCARD Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Immunoadsorption Columns Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunoadsorption Columns Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Immunoadsorption Columns Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Immunoadsorption Columns Sales Market Share by Country/Region (2025)
Figure 8. Immunoadsorption Columns Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Immunoadsorption Columns Market Size Market Share by Type in 2025
Figure 10. Global Immunoadsorption Columns Market Size Market Share by Ligand Composition in 2025
Figure 11. Global Immunoadsorption Columns Market Size Market Share by Carrier Matrix in 2025
Figure 12. Immunoadsorption Columns in Hospitals
Figure 13. Global Immunoadsorption Columns Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Immunoadsorption Columns in Specialty Clinics
Figure 15. Global Immunoadsorption Columns Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 16. Immunoadsorption Columns in Academic & Research Centres
Figure 17. Global Immunoadsorption Columns Market: Academic & Research Centres (2021-2026) & ($ millions)
Figure 18. Immunoadsorption Columns in Others
Figure 19. Global Immunoadsorption Columns Market: Others (2021-2026) & ($ millions)
Figure 20. Global Immunoadsorption Columns Market Size Market Share by Application in 2025
Figure 21. Global Immunoadsorption Columns Revenue Market Share by Player in 2025
Figure 22. Global Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Figure 23. Americas Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 24. APAC Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 25. Europe Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 27. Americas Immunoadsorption Columns Value Market Share by Country in 2025
Figure 28. United States Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Immunoadsorption Columns Market Size Market Share by Region in 2025
Figure 33. APAC Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Figure 34. APAC Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Figure 35. China Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 39. India Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Immunoadsorption Columns Market Size Market Share by Country in 2025
Figure 42. Europe Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Figure 43. Europe Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Figure 44. Germany Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 45. France Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 58. APAC Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 59. Europe Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 61. United States Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 62. Canada Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 63. Mexico Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 64. Brazil Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 65. China Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 66. Japan Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 67. Korea Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 69. India Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 70. Australia Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 71. Germany Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 72. France Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 73. UK Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 74. Italy Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 75. Russia Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 76. Egypt Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 77. South Africa Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 78. Israel Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 79. Turkey Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 80. Global Immunoadsorption Columns Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Immunoadsorption Columns Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 1. Immunoadsorption Columns Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunoadsorption Columns Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Immunoadsorption Columns Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Immunoadsorption Columns Sales Market Share by Country/Region (2025)
Figure 8. Immunoadsorption Columns Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Immunoadsorption Columns Market Size Market Share by Type in 2025
Figure 10. Global Immunoadsorption Columns Market Size Market Share by Ligand Composition in 2025
Figure 11. Global Immunoadsorption Columns Market Size Market Share by Carrier Matrix in 2025
Figure 12. Immunoadsorption Columns in Hospitals
Figure 13. Global Immunoadsorption Columns Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Immunoadsorption Columns in Specialty Clinics
Figure 15. Global Immunoadsorption Columns Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 16. Immunoadsorption Columns in Academic & Research Centres
Figure 17. Global Immunoadsorption Columns Market: Academic & Research Centres (2021-2026) & ($ millions)
Figure 18. Immunoadsorption Columns in Others
Figure 19. Global Immunoadsorption Columns Market: Others (2021-2026) & ($ millions)
Figure 20. Global Immunoadsorption Columns Market Size Market Share by Application in 2025
Figure 21. Global Immunoadsorption Columns Revenue Market Share by Player in 2025
Figure 22. Global Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Figure 23. Americas Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 24. APAC Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 25. Europe Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Immunoadsorption Columns Market Size 2021-2026 ($ millions)
Figure 27. Americas Immunoadsorption Columns Value Market Share by Country in 2025
Figure 28. United States Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Immunoadsorption Columns Market Size Market Share by Region in 2025
Figure 33. APAC Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Figure 34. APAC Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Figure 35. China Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 39. India Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Immunoadsorption Columns Market Size Market Share by Country in 2025
Figure 42. Europe Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Figure 43. Europe Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Figure 44. Germany Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 45. France Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Immunoadsorption Columns Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Immunoadsorption Columns Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Immunoadsorption Columns Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Immunoadsorption Columns Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 58. APAC Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 59. Europe Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 61. United States Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 62. Canada Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 63. Mexico Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 64. Brazil Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 65. China Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 66. Japan Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 67. Korea Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 69. India Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 70. Australia Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 71. Germany Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 72. France Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 73. UK Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 74. Italy Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 75. Russia Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 76. Egypt Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 77. South Africa Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 78. Israel Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 79. Turkey Immunoadsorption Columns Market Size 2027-2032 ($ millions)
Figure 80. Global Immunoadsorption Columns Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Immunoadsorption Columns Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Immunoadsorption Columns Market Size 2027-2032 ($ millions)
